
Investors Face September Deadline in Procept BioRobotics Class Action
A 75% collapse in Procept BioRobotics stock has triggered a securities class action, forcing institutional investors to reconcile potential losses. The lawsuit centers on allegations that the company masked weak demand for its AquaBeam Robotic Systems through an aggressive handpiece discount program that artificially inflated revenue metrics.


























